HOME >> BIOLOGY >> NEWS
A novel molecular dictator 'with a conscience' discovered

University of New South Wales (UNSW) researchers have uncovered an important naturally occurring mechanism in the body where "bad" cells that cause blockages in our blood vessels are kept under strict growth control, while "good" cells that keep our blood vessels free of clots and growths are left unaffected.

The discovery is expected to benefit those who will need heart coronary bypass surgery, an angioplasty - the mechanical widening of a narrowed or totally blocked blood vessel - or will undergo haemodialysis.

Professor Levon Khachigian, from UNSWs Centre for Vascular Research, who previously pioneered "molecular assassin" drug technology, describes this novel mechanism he discovered as a molecular dictatorship with a conscience.

"The dictator is a specific gene suppressor called YY1, which has the therapeutically appealing capacity to differentiate between certain cell types when it goes about its activity," says Professor Khachigian.

This key finding has just been published in the world's premier cardiovascular research journal, Circulation Research.

Professor Khachigian's research provides new hope in tackling the global problems of coronary bypass graft failure, and restenosis - the closing or narrowing of an artery that was previously opened by a procedure such as angioplasty.

"While the most effective way to head off restenosis is a drug-coated stent, the drugs that sit on these stents inhibit the growth of good cells as well as the bad.

If you had to have catheter intervention to re-open an occluded artery, for sustained symptom-free benefit you would be hoping for suppressed smooth muscle cell growth, without affecting endothelial cell growth, says Professor Khachigian.

And thats exactly what happens when we simply top up blood vessels with the bodys natural reserves of YY1."


'"/>

Contact: Susi Hamilton
susi.hamilton@unsw.edu.au
61-422-934-024
University of New South Wales
22-Jul-2007


Page: 1

Related biology news :

1. CTRC enrolls first patients in novel phase II study for sarcoma -- living virus destroys cancer cell
2. UB scientist discovers novel iron-copper alliance
3. Researchers pit novel version of common virus against cancer
4. UCLA researchers discover novel pathway that may promote immune system balance
5. pHLIP, a novel technology to locate and treat tumors
6. Bioluminescence at the service of a novel cerebral imaging technique
7. Application of Genomatix in silico methods reveals novel cancer associated genes
8. Two studies: Speeding development of novel tracer for prostate cancer
9. Erythrocyte G protein as a novel target for malarial chemotherapy
10. U of MN researchers find novel genes critical in organ development
11. PATH Malaria Vaccine Initiative announces partnership to develop novel malaria vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/27/2019)... ... August 27, 2019 , ... Ambry ... to improve genetic testing guidelines. In the largest cohort study of its kind, ... more at-risk patients. , Clinicians use guidelines to inform decisions about which ...
(Date:8/21/2019)... ... August 21, 2019 , ... AbSci, a revolutionary synthetic biology ... biomanufacturing of complex protein therapeutics, today announced the appointment of Fred Larimore, PhD, ... Dr. Larimore brings more than 30 years of experience in biopharmaceutical manufacturing and ...
(Date:8/15/2019)... (PRWEB) , ... August 15, 2019 , ... ... passed. Now what? As serialization mandates become increasingly complex, and aggregation becomes fully ... current serialization software is the best long-term solution. , Until now, most regulations?including ...
Breaking Biology News(10 mins):
(Date:9/8/2019)... , ... September 05, 2019 , ... ... Blaine Fitzgerald, former Vice President of Finance for Shopify, has been named Chief ... and healthcare venture capitalist Joel Finlayson as strategic advisors. Additionally, Spartan has hired ...
(Date:8/29/2019)... ... August 28, 2019 , ... ... DuPont™ Danisco® ingredient solutions to attendees at the International Baking Industry Expo, September ... baking challenges from optimizing production efficiency to cost and waste reduction and from ...
(Date:8/25/2019)... ... August 23, 2019 , ... ... 1 best-selling status for the scientific research book “Impact of Biofield Treatment on ... and perfume industry as Patchouli. , The book garnered No. 1 status ...
(Date:8/14/2019)... ... August 13, 2019 , ... INDIGO ... toxicology testing solutions, announced the appointment of Mark McLoughlin to the Company’s Board ... , Mark McLoughlin will lend his healthcare expertise and extensive background in laboratory ...
Breaking Biology Technology:
Cached News: